Safety and Effects of Ramipril Combined With Candesartan
Launched by GACHON UNIVERSITY GIL MEDICAL CENTER · Jul 25, 2006
Trial Information
Current as of June 23, 2025
Completed
Keywords
ClinConnect Summary
Forty patients will be given ramipril 10 mg and placebo, ramipril 10 mg and candesartan 16 mg, or candesartan 16 mg and placebo daily in a randomized, double-blind, placebo-controlled cross-over trial with three treatment arms and two washout periods (each 2 months).
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients with mild to moderate hypertension
- Exclusion Criteria:
- • We will exclude patients with severe hypertension, unstable angina, acute myocardial infarction, or renal insufficiency.
About Gachon University Gil Medical Center
Gachon University Gil Medical Center is a leading healthcare institution located in South Korea, renowned for its commitment to advancing medical research and clinical excellence. As a prominent clinical trial sponsor, the center leverages its comprehensive expertise in various medical fields to facilitate innovative research initiatives aimed at improving patient outcomes. With a strong focus on collaboration, Gachon University Gil Medical Center engages in partnerships with academic institutions, industry leaders, and healthcare professionals to drive the development of groundbreaking therapies and treatment modalities. Its state-of-the-art facilities and dedicated research teams ensure rigorous adherence to ethical standards and regulatory compliance, positioning the center at the forefront of clinical research in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Kwang K Koh, MD
Principal Investigator
Cardiology, Gil Heart Center, Gachon Medical School
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials